ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PXS Provexis Plc

0.60
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Provexis Plc LSE:PXS London Ordinary Share GB00B0923P27 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.60 0.55 0.65 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Food Preparations, Nec 390k -385k -0.0002 -30.00 13.31M
Provexis Plc is listed in the Food Preparations sector of the London Stock Exchange with ticker PXS. The last closing price for Provexis was 0.60p. Over the last year, Provexis shares have traded in a share price range of 0.448p to 0.90p.

Provexis currently has 2,217,821,523 shares in issue. The market capitalisation of Provexis is £13.31 million. Provexis has a price to earnings ratio (PE ratio) of -30.00.

Provexis Share Discussion Threads

Showing 45351 to 45369 of 47425 messages
Chat Pages: Latest  1825  1824  1823  1822  1821  1820  1819  1818  1817  1816  1815  1814  Older
DateSubjectAuthorDiscuss
16/8/2016
19:22
The fence welcomes everyone, and most of the silent majority are likely to be sat on it.

The annual report will probsbly be too early for them to know, but it would be nice to get a trading update with the AGM statement giving an idea of how much income we're expecting from DSM for H1.

I'm not really expecting that though, but they should be able to tell us what the revenue from FF+ is, and whether it's profitable.

Wheelie will be selling some soon, and calming down a bit ...and fair play to him for making a profit.

BB

bareknee
15/8/2016
12:28
Oops, I'm going to sound like Bernie. :(
You're both right yet both selective.

WheelieBin; 40% rise is good and although I missed my limit order at 0.26p, my latest topup, albeit the only one, is in profit. If this rise is associated with fundamentals-changing news, it's likely to continue. Yet, this 0.1p rise pales into insignificance compared to the approx. 8.0p fall since I first bought this stock a few years ago.

RP; market expectations clearly have improved and it looks like we can reasonably assume further improvement from here.

Look at me, it's a bloody miracle; I'm on the fence. Bernie would be so proud.

If I were a ramper (which I'm not), now might be the right time to shout PXS from the rooftops of whatever sordid little office they work from.

librag
15/8/2016
01:00
We have had a terrible last 5 years but all being well we are hopefully now on the mend which will be highlighted come this September..IMHO

07:00 02-Aug-2016 PXS Results of Placing RNS +2.44% Up
07:00 12-Jul-2016 PXS Study Publication RNS +5.39% Up
07:05 29-Jun-2016 PXS Funding Update RNS +8.61% Up
07:00 29-Jun-2016 PXS Product Launch RNS +8.61% Up

July low share price 0.26p today 0.36p = 40% rise in one month.

Preliminary Results
September 2016
Annual General Meeting
30 September 2016

wheelds
14/8/2016
12:23
wheelds - market expectations have not imo improved at all.What evidence is there of that?A minor rise from woeful lows is not evidence of that.

We are loss making with insufficient monies to guarantee even the next financial year.That is not an improvement.The last "fundraising" which was a mates rate discount fund raiser amounted to a temporary reprieve at best.

Clutching at straws again.

redprince
14/8/2016
03:08
It looks like the market expectations for Provexis has improved, and the rise in the share price seems to confirm this factor since the last fund raising to give us enough cash to keep going as revenues increase:-

"In June 2015 the Company confirmed it had agreed significantly enhanced financial terms for its Alliance Agreement with DSM for Fruitflow®."

wheelds
05/8/2016
01:12
"STATINS INCREASE RISK OF DIABETES" Says front page of Daily Express.
"Doubling the costs to the N.H.S. in a decade to £1 billion a year."

Front page of the Daily Express all about new evidence showing connection between taking Statins for heart health and triggering off diabetes in many and the number of people now developing Diabetes is on the increase.

Good time to advertise in say the Daily Express or to get a reporter to check out our Fruitflow plus omega 3 compared to Statins for healthy heart with no side effects like Diabetes; and published the findings this week following on from this scare story.. In my opinion. .

wheelds
02/8/2016
08:41
No surprise.
The BoD putting their own money on the line though ... certainly IS.

I've got a topup order in @ 0.26p, we'll see if it gets taken. GL.

librag
02/8/2016
08:38
Placing. There's asurprise.

LOL!

More 'tomatoes tomorrow'??

They have been spinning this story for years, and years and.....

Makes one wonder: if this supposedly soopa-doopa thingummy was indeed so miraculous, would it not have been snapped up by GSK &/or AZN a long time ago.

2magpies
27/7/2016
16:56
You can try Amazon for the juice or buy in tablet form direct from Provexis.
redprince
27/7/2016
11:55
Good news!
If you need shopping advice, you have a shopping choice, either the red channel or the blue channel.
:)

librag
26/7/2016
21:45
Sainsburys have stopped selling Sirco.
Disaster!
Anyone know where I can buy it now?
Tia TFC

the fat controller
26/7/2016
14:19
Graham

Well done on St Ives, that's recovered nicely for you !

As far as Provexis goes, for me, without the BP R&D, this isn't really investable for me in in the short to medium term. Even stripping out the R&D costs of a bit under 200k / year, this could take 18+ months just to break even.

We have to wait for the trial results come out, which should be looked on as a stop-go. If they show some statistical significance, then the BoD should be looking to fund the next stage. If not, then this is likely to continue to stagnate. Worst case is the results aren't very significant and we continue to
throw cash at it to keep Dutta Roy sweet.

DSM will buy us out if it's makes economic sense for them to do so. At the moment, with an annualised cost for them for the profit share of 100k and a market cap of ~4.5 million, they'd be nuts to try and take us out.

BB

bareknee
22/7/2016
14:01
LibraG - they need to detail grounds for exclusivity as non exclusive is a clear barrier to entry that suits their purpose and not ours.

We could easily ask for eg 3 year limited exclusivity for certain launches which would buy us time.

We must ask for shareholder representation on the Alliance - long overdue.
We are being mugged off with an online product that does nothing to address our real concerns.

redprince
22/7/2016
10:27
RP; be careful what you wish for. If PXS don't go for more fund raising to fund R&D, you might find that the BoD, in our "best interests" believe there's nothing to be gained from continuing in business.

I know that we don't know what's really going on but you (and I) are rightly worried and suspicious that DSM might be deliberately playing a waiting game. Let's get some competition on what would otherwise be a monopoly control.

Paranoid? You bet.

Bernie: thoughts?

librag
20/7/2016
12:58
Hopefully SIV will move following that :-). this looks like it might correct above >0.3p to me. could be wrong.....
senor_sensible
20/7/2016
12:21
Hi SS; it's so interesting, .... not. SIV on the other hand - about time it woke up and £100K worth of director buys is great news ... shame about our BoD.
librag
20/7/2016
10:16
interesting volume today... :-)
senor_sensible
12/7/2016
11:25
Graham

St Ives are a fairly well run company and did quite well for me for three or four years. They seem to have over reached themselves a bit. If you've spotted a technical bounce opportunity or something, then good luck.

If you're in as something longer term then the next trading update will be important. I reckon there's a one in four chance of them raising some cash from the markets ( at a discount ). Obviously that means I think there's a three in four chance they won't, but, if you've read my witterings on them for the last few years you'll know their accounts are tough to get to the bottom of.

They have a lot more debt now than they did three or four years ago, so I'm avoiding the temptation to buy back in just yet.

As for Provexis, I'm wondering whether to put a bid into Primary Bid for a few k at .24p to see if they take it up at the same time as the hoped for placing. Can't be much more than a couple of months before they need the cash in the bank.

BB

bareknee
08/7/2016
16:49
LOL

I knew you wouldn't be able to resist commenting on that !

Anyway, I've had a better look at it and it IS a very good paper and will be useful when talking to prospective customers ( companies ), but it's also preaching to the converted somewhat so it's just part of a tricky process to convince companies there's a decent sized market for Fruitflow.

They need to sort out the short term finances though. Raising 185k may well not be enough to get the accounts signed off as a going concern. It'll be a bit touch and go. If you ( or anyone else reading this ) wants to buy say 5k or more in value of shares then I'd suggest you contact Ford and say you'll take [n]k's worth at .24 in the placing.

BB

bareknee
Chat Pages: Latest  1825  1824  1823  1822  1821  1820  1819  1818  1817  1816  1815  1814  Older

Your Recent History

Delayed Upgrade Clock